Raja Sawhney, MD
Otolaryngology · Orange Park, FLNPI 1962612184
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,200 of the $18,537 with a category attached, or 65.8%. Synthes GmbH accounts for 94.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $5,503 and has fallen 50.7% since, to $2,714 in 2025. Among otolaryngology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $298.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$18K
- Medtronic$269
- Sun Pharmaceutical Industries Inc.$120
- Regeneron Healthcare Solutions, Inc.$100
- Axogen$64
- Organogenesis Inc.$61
- plus $386 from 11 others
What the payments were for
- Speaking & faculty fees$12,20066%
- Travel & lodging$4,47524%
- Food & beverage$1,86210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 22 | $17,537 |
| Medtronic | 9 | $269 |
| Sun Pharmaceutical Industries Inc. | 5 | $120 |
| Regeneron Healthcare Solutions, Inc. | 4 | $100 |
| Axogen | 1 | $64 |
| Organogenesis Inc. | 2 | $61 |
| Stryker | 2 | $56 |
| AbbVie | 3 | $53 |
| Kerecis Limited | 4 | $51 |
| Acclarent, Inc | 1 | $48 |
| Amgen | 2 | $41 |
| Biofrontera Inc. | 2 | $38 |
| Convatec Inc. | 1 | $26 |
| Boehringer Ingelheim | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| LEO Pharma Inc. | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
How this compares
$18,537 in reported general payments places this provider in the 90th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 49 | $2,173 |
| Cephalexin | 49 | $597 |
| Doxycycline Hyclate | 13 | $114 |
| Mupirocin | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Orange Park
- Nicholas HerreroOrange Park$27K
- Cecelia DamaskOrlando$707K
- Ralph TufanoSarasota$469K
- Franklin RimellFort Myers$314K
- David BrodnerBoynton Beach$209K
- Maria SuurnaMiami$189K
- Jane DillonOrmond Beach$180K
- Jeb JusticeGainesville$142K
- Indranil DebnathWinter Park$109K
- Agustin ArrietaMiami$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.